A lower dose of the vaccine showed to be safe, well-tolerated and effective in spurring antibodies in kids between 5 to 11 years of age, the company announced.
from Livescience.com https://ift.tt/2Z3I2Vt
via IFTTT
from Livescience.com https://ift.tt/2Z3I2Vt
via IFTTT
Comments
Post a Comment